Neogen Corporation Increase (Decrease) in Accounts Receivable
Neogen Corporation (NEOG) reported Increase (Decrease) in Accounts Receivable of -$6.80 million for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-07-30
- Neogen Corporation increase (decrease) in accounts receivable for the quarter ending 2026-05-31 was $9.80M.
- Neogen Corporation increase (decrease) in accounts receivable for the quarter ending 2026-02-28 was -$5.25M.
- Neogen Corporation increase (decrease) in accounts receivable for the quarter ending 2025-11-30 was $6.26M.
- Neogen Corporation increase (decrease) in accounts receivable for the quarter ending 2025-08-31 was -$17.61M.
- Neogen Corporation increase (decrease) in accounts receivable for fiscal 2026 was -$6.80M.
- Neogen Corporation increase (decrease) in accounts receivable for fiscal 2025 was -$11.60M, a 157.71% decline from fiscal 2024.
- Neogen Corporation increase (decrease) in accounts receivable for fiscal 2024 was $20.10M, a 62.69% decline from fiscal 2023.
- Neogen Corporation increase (decrease) in accounts receivable for fiscal 2023 was $53.88M, a 590.93% increase from fiscal 2022.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 9 month as first filed | Increase (Decrease) in Accounts Receivable 12 month | Increase (Decrease) in Accounts Receivable 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-05-31 | $9.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-30 | $4.55M derived: sum of 2 quarters · filed 2026-07-30 | $10.81M derived: sum of 3 quarters · filed 2026-07-30 | -$6.80M 10-K · filed 2026-07-30 | ||
| 2026-02-28 | -$5.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-09 | $1.01M derived: sum of 2 quarters · filed 2026-04-09 | -$16.60M 10-Q · filed 2026-04-09 | -$19.10M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-11-30 | $6.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-01-08 | -$11.35M 10-Q · filed 2026-01-08 | -$13.85M derived: sum of 3 quarters · filed 2026-07-30 | -$17.62M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-08-31 | -$17.61M 10-Q · filed 2025-10-09 | -$20.11M derived: sum of 2 quarters · filed 2026-07-30 | -$23.88M derived: sum of 3 quarters · filed 2026-07-30 | -$24.41M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-05-31 | -$2.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-30 | -$6.27M derived: sum of 2 quarters · filed 2026-07-30 | -$6.80M derived: sum of 3 quarters · filed 2026-07-30 | -$11.60M 10-K · filed 2026-07-30 | -$11.64M 10-K · filed 2025-07-30 | |
| 2025-02-28 | -$3.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-09 | -$4.30M derived: sum of 2 quarters · filed 2026-04-09 | -$9.10M 10-Q · filed 2026-04-09 | -$9.13M 10-Q · filed 2025-04-09 | -$5.14M derived: sum of 4 quarters · filed 2026-07-30 | |
| 2024-11-30 | -$536.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-01-08 | -$5.33M 10-Q · filed 2026-01-08 | -$1.37M derived: sum of 3 quarters · filed 2026-07-30 | $18.40M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2024-08-31 | -$4.80M 10-Q · filed 2025-10-09 | -$832.00K derived: sum of 2 quarters · filed 2026-07-30 | $18.94M derived: sum of 3 quarters · filed 2026-07-30 | $31.55M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2024-05-31 | $3.96M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-30 | $23.73M derived: sum of 2 quarters · filed 2026-07-30 | $36.34M derived: sum of 3 quarters · filed 2026-07-30 | $20.10M 10-K · filed 2026-07-30 | $20.10M 10-K · filed 2024-07-30 | |
| 2024-02-29 | $19.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-04-09 | $32.38M derived: sum of 2 quarters · filed 2025-04-09 | $16.14M 10-Q · filed 2025-04-09 | $22.48M derived: sum of 4 quarters · filed 2025-07-30 | ||
| 2023-11-30 | $12.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-01-15 | -$3.63M 10-Q · filed 2025-01-15 | $2.71M derived: sum of 3 quarters · filed 2025-07-30 | $5.79M derived: sum of 4 quarters · filed 2025-07-30 | ||
| 2023-08-31 | -$16.24M 10-Q · filed 2024-10-10 | -$9.90M derived: sum of 2 quarters · filed 2025-07-30 | -$6.82M derived: sum of 3 quarters · filed 2025-07-30 | $42.46M derived: sum of 4 quarters · filed 2025-07-30 | ||
| 2023-05-31 | $6.34M derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-30 | $9.43M derived: sum of 2 quarters · filed 2025-07-30 | $58.70M derived: sum of 3 quarters · filed 2025-07-30 | $53.88M 10-K · filed 2025-07-30 | ||
| 2023-02-28 | $3.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-04-09 | $52.35M derived: sum of 2 quarters · filed 2024-04-09 | $47.53M 10-Q · filed 2024-04-09 | $54.45M derived: sum of 4 quarters · filed 2024-07-30 | ||
| 2022-11-30 | $49.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-01-09 | $44.45M 10-Q · filed 2024-01-09 | $51.37M derived: sum of 3 quarters · filed 2024-07-30 | $50.75M derived: sum of 4 quarters · filed 2024-07-30 | ||
| 2022-08-31 | -$4.82M 10-Q · filed 2023-10-10 | $2.10M derived: sum of 2 quarters · filed 2024-07-30 | $1.48M derived: sum of 3 quarters · filed 2024-07-30 | $7.01M derived: sum of 4 quarters · filed 2024-07-30 | ||
| 2022-05-31 | $6.92M derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-30 | $6.30M derived: sum of 2 quarters · filed 2024-07-30 | $11.83M derived: sum of 3 quarters · filed 2024-07-30 | $7.80M 10-K · filed 2024-07-30 | ||
| 2022-02-28 | -$617.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-04-04 | $4.92M derived: sum of 2 quarters · filed 2023-04-04 | $883.00K 10-Q · filed 2023-04-04 | $4.50M derived: sum of 4 quarters · filed 2023-08-15 | ||
| 2021-11-30 | $5.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-01-09 | $1.50M 10-Q · filed 2023-01-09 | $5.11M derived: sum of 3 quarters · filed 2023-08-15 | $10.76M derived: sum of 4 quarters · filed 2023-08-15 | ||
| 2021-08-31 | -$4.04M 10-Q · filed 2022-09-30 | -$422.00K derived: sum of 2 quarters · filed 2023-08-15 | $5.22M derived: sum of 3 quarters · filed 2023-08-15 | $6.91M derived: sum of 4 quarters · filed 2023-08-15 | ||
| 2021-05-31 | $3.61M derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-15 | $9.26M derived: sum of 2 quarters · filed 2023-08-15 | $10.95M derived: sum of 3 quarters · filed 2023-08-15 | $2.60M 10-K · filed 2023-08-15 | ||
| 2021-02-28 | $5.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-04-01 | $7.33M derived: sum of 2 quarters · filed 2022-04-01 | -$1.02M 10-Q · filed 2022-04-01 | $5.70M derived: sum of 4 quarters · filed 2022-07-27 | ||
| 2020-11-30 | $1.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-12-30 | -$6.66M 10-Q · filed 2021-12-30 | $60.00K derived: sum of 3 quarters · filed 2022-07-27 | -$6.26M derived: sum of 4 quarters · filed 2022-07-27 | ||
| 2020-08-31 | -$8.35M 10-Q · filed 2021-09-30 | -$1.63M derived: sum of 2 quarters · filed 2022-07-27 | -$7.95M derived: sum of 3 quarters · filed 2022-07-27 | -$2.08M derived: sum of 4 quarters · filed 2022-07-27 | ||
| 2020-05-31 | $6.72M derived: 10-K 12 month − 10-Q 9 month · filed 2022-07-27 | $398.00K derived: sum of 2 quarters · filed 2022-07-27 | $6.27M derived: sum of 3 quarters · filed 2022-07-27 | $2.88M 10-K · filed 2022-07-27 | ||
| 2020-02-29 | -$6.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-03-31 | -$451.00K derived: sum of 2 quarters · filed 2021-03-31 | -$3.84M 10-Q · filed 2021-03-31 | -$714.00K derived: sum of 4 quarters · filed 2021-07-30 | ||
| 2019-11-30 | $5.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-12-29 | $2.48M 10-Q · filed 2020-12-29 | $5.61M derived: sum of 3 quarters · filed 2021-07-30 | $2.89M derived: sum of 4 quarters · filed 2021-07-30 | ||
| 2019-08-31 | -$3.39M 10-Q · filed 2020-09-30 | -$263.00K derived: sum of 2 quarters · filed 2021-07-30 | -$2.98M derived: sum of 3 quarters · filed 2021-07-30 | $1.39M derived: sum of 4 quarters · filed 2021-07-30 | ||
| 2019-05-31 | $3.13M derived: 10-K 12 month − 10-Q 9 month · filed 2021-07-30 | $410.00K derived: sum of 2 quarters · filed 2021-07-30 | $4.78M derived: sum of 3 quarters · filed 2021-07-30 | $4.03M 10-K · filed 2021-07-30 | ||
| 2019-02-28 | -$2.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-04-03 | $1.65M derived: sum of 2 quarters · filed 2020-04-03 | $898.00K 10-Q · filed 2020-04-03 | $7.12M derived: sum of 4 quarters · filed 2020-07-30 | ||
| 2018-11-30 | $4.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-12-27 | $3.62M 10-Q · filed 2019-12-27 | $9.84M derived: sum of 3 quarters · filed 2020-07-30 | $7.99M derived: sum of 4 quarters · filed 2020-07-30 | ||
| 2018-08-31 | -$755.00K 10-Q · filed 2019-09-26 | $5.46M derived: sum of 2 quarters · filed 2020-07-30 | $3.62M derived: sum of 3 quarters · filed 2020-07-30 | $11.71M derived: sum of 4 quarters · filed 2020-07-30 | ||
| 2018-05-31 | $6.22M derived: 10-K 12 month − 10-Q 9 month · filed 2020-07-30 | $4.37M derived: sum of 2 quarters · filed 2020-07-30 | $12.46M derived: sum of 3 quarters · filed 2020-07-30 | $10.23M 10-K · filed 2020-07-30 | ||
| 2018-02-28 | -$1.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-03-29 | $6.24M derived: sum of 2 quarters · filed 2019-03-29 | $4.01M 10-Q · filed 2019-03-29 | $4.89M derived: sum of 4 quarters · filed 2019-07-30 | ||
| 2017-11-30 | $8.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-12-28 | $5.86M 10-Q · filed 2018-12-28 | $6.74M derived: sum of 3 quarters · filed 2019-07-30 | $2.67M derived: sum of 4 quarters · filed 2019-07-30 | ||
| 2017-08-31 | -$2.23M 10-Q · filed 2018-10-05 | -$1.35M derived: sum of 2 quarters · filed 2019-07-30 | -$5.42M derived: sum of 3 quarters · filed 2019-07-30 | $422.00K derived: sum of 4 quarters · filed 2019-07-30 | ||
| 2017-05-31 | $881.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-07-30 | -$3.19M derived: sum of 2 quarters · filed 2019-07-30 | $2.65M derived: sum of 3 quarters · filed 2019-07-30 | -$5.04M 10-K · filed 2019-07-30 | ||
| 2017-02-28 | -$4.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-03-29 | $1.77M derived: sum of 2 quarters · filed 2018-03-29 | -$5.92M 10-Q · filed 2018-03-29 | $3.60M derived: sum of 4 quarters · filed 2018-07-27 | ||
| 2016-11-30 | $5.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-01-05 | -$1.85M 10-Q · filed 2018-01-05 | $7.67M derived: sum of 3 quarters · filed 2018-07-27 | $6.67M derived: sum of 4 quarters · filed 2018-07-27 | ||
| 2016-08-31 | -$7.68M 10-Q · filed 2017-09-29 | $1.83M derived: sum of 2 quarters · filed 2018-07-27 | $832.00K derived: sum of 3 quarters · filed 2018-07-27 | -$473.00K derived: sum of 4 quarters · filed 2018-07-27 | ||
| 2016-05-31 | $9.51M derived: 10-K 12 month − 10-Q 9 month · filed 2018-07-27 | $8.52M derived: sum of 2 quarters · filed 2018-07-27 | $7.21M derived: sum of 3 quarters · filed 2018-07-27 | $6.00M 10-K · filed 2018-07-27 | ||
| 2016-02-29 | -$998.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-03-31 | -$2.30M derived: sum of 2 quarters · filed 2017-03-31 | -$3.51M 10-Q · filed 2017-03-31 | $2.86M derived: sum of 4 quarters · filed 2017-07-28 | ||
| 2015-11-30 | -$1.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-12-29 | -$2.51M 10-Q · filed 2016-12-29 | $3.85M derived: sum of 3 quarters · filed 2017-07-28 | $4.65M derived: sum of 4 quarters · filed 2017-07-28 | ||
| 2015-08-31 | -$1.21M 10-Q · filed 2016-09-30 | $5.16M derived: sum of 2 quarters · filed 2017-07-28 | $5.95M derived: sum of 3 quarters · filed 2017-07-28 | $6.20M derived: sum of 4 quarters · filed 2017-07-28 | ||
| 2015-05-31 | $6.37M derived: 10-K 12 month − 10-Q 9 month · filed 2017-07-28 | $7.16M derived: sum of 2 quarters · filed 2017-07-28 | $7.41M derived: sum of 3 quarters · filed 2017-07-28 | $7.25M 10-K · filed 2017-07-28 | ||
| 2015-02-28 | $793.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-03-31 | $1.04M derived: sum of 2 quarters · filed 2016-03-31 | $884.00K 10-Q · filed 2016-03-31 | $4.70M derived: sum of 4 quarters · filed 2016-07-29 | ||
| 2014-11-30 | $246.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-01-08 | $91.00K 10-Q · filed 2016-01-08 | $3.90M derived: sum of 3 quarters · filed 2016-07-29 | $5.69M derived: sum of 4 quarters · filed 2016-07-29 | ||
| 2014-08-31 | -$155.00K 10-Q · filed 2015-09-30 | $3.66M derived: sum of 2 quarters · filed 2016-07-29 | $5.45M derived: sum of 3 quarters · filed 2016-07-29 | $6.38M derived: sum of 4 quarters · filed 2016-07-29 | ||
| 2014-05-31 | $3.81M derived: 10-K 12 month − 10-Q 9 month · filed 2016-07-29 | $5.60M derived: sum of 2 quarters · filed 2016-07-29 | $6.53M derived: sum of 3 quarters · filed 2016-07-29 | $10.60M 10-K · filed 2016-07-29 | ||
| 2014-02-28 | $1.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-04-01 | $2.72M derived: sum of 2 quarters · filed 2015-04-01 | $6.79M 10-Q · filed 2015-04-01 | $6.86M derived: sum of 4 quarters · filed 2015-07-30 | ||
| 2013-11-30 | $932.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-12-30 | $5.00M 10-Q · filed 2014-12-30 | $5.07M derived: sum of 3 quarters · filed 2015-07-30 | $6.38M derived: sum of 4 quarters · filed 2015-07-30 | ||
| 2013-08-31 | $4.07M 10-Q · filed 2014-09-30 | $4.14M derived: sum of 2 quarters · filed 2015-07-30 | $5.45M derived: sum of 3 quarters · filed 2015-07-30 | $4.95M derived: sum of 4 quarters · filed 2015-07-30 | ||
| 2013-05-31 | $67.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-30 | $1.38M derived: sum of 2 quarters · filed 2015-07-30 | $884.00K derived: sum of 3 quarters · filed 2015-07-30 | $2.67M 10-K · filed 2015-07-30 | ||
| 2013-02-28 | $1.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-04-04 | $817.00K derived: sum of 2 quarters · filed 2014-04-04 | $2.61M 10-Q · filed 2014-04-04 | $4.12M derived: sum of 4 quarters · filed 2014-07-30 | ||
| 2012-11-30 | -$493.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-01-09 | $1.30M 10-Q · filed 2014-01-09 | $2.81M derived: sum of 3 quarters · filed 2014-07-30 | $5.27M derived: sum of 4 quarters · filed 2014-07-30 | ||
| 2012-08-31 | $1.79M 10-Q · filed 2013-09-30 | $3.30M derived: sum of 2 quarters · filed 2014-07-30 | $5.76M derived: sum of 3 quarters · filed 2014-07-30 | $4.96M derived: sum of 4 quarters · filed 2014-07-30 | ||
| 2012-05-31 | $1.51M derived: 10-K 12 month − 10-Q 9 month · filed 2014-07-30 | $3.97M derived: sum of 2 quarters · filed 2014-07-30 | $3.17M derived: sum of 3 quarters · filed 2014-07-30 | $7.20M 10-K · filed 2014-07-30 | ||
| 2012-02-29 | $2.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-03-28 | $1.66M derived: sum of 2 quarters · filed 2013-03-28 | $5.70M 10-Q · filed 2013-03-28 | $5.14M derived: sum of 4 quarters · filed 2013-07-30 | ||
| 2011-11-30 | -$804.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-12-28 | $3.23M 10-Q · filed 2012-12-28 | $2.68M derived: sum of 3 quarters · filed 2013-07-30 | $3.92M derived: sum of 4 quarters · filed 2013-07-30 | ||
| 2011-08-31 | $4.04M 10-Q · filed 2012-09-28 | $3.48M derived: sum of 2 quarters · filed 2013-07-30 | $4.73M derived: sum of 3 quarters · filed 2013-07-30 | $5.63M derived: sum of 4 quarters · filed 2013-07-30 | ||
| 2011-05-31 | -$557.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-07-30 | $688.00K derived: sum of 2 quarters · filed 2013-07-30 | $1.59M derived: sum of 3 quarters · filed 2013-07-30 | $903.00K 10-K · filed 2013-07-30 | ||
| 2011-02-28 | $1.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-03-30 | $2.14M derived: sum of 2 quarters · filed 2012-03-30 | $1.46M 10-Q · filed 2012-03-30 | |||
| 2010-11-30 | $898.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2011-12-30 | $215.00K 10-Q · filed 2011-12-30 | ||||
| 2010-08-31 | -$683.00K 10-Q · filed 2011-09-30 | |||||
| 2010-05-31 | $2.24M 10-K · filed 2012-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |